202 related articles for article (PubMed ID: 27107087)
1. Strain Analysis in the Assessment of a Mouse Model of Cardiotoxicity due to Chemotherapy: Sample for Preclinical Research.
Rea D; Coppola C; Barbieri A; Monti MG; Misso G; Palma G; Bimonte S; Zarone MR; Luciano A; Liccardo D; Maiolino P; Cittadini A; Ciliberto G; Arra C; Maurea N
In Vivo; 2016; 30(3):279-90. PubMed ID: 27107087
[TBL] [Abstract][Full Text] [Related]
2. Screening for
Chakouri N; Farah C; Matecki S; Amedro P; Vincenti M; Saumet L; Vergely L; Sirvent N; Lacampagne A; Cazorla O
Theranostics; 2020; 10(18):8130-8142. PubMed ID: 32724462
[TBL] [Abstract][Full Text] [Related]
3. Rac1-mediated cardiac damage causes diastolic dysfunction in a mouse model of subacute doxorubicin-induced cardiotoxicity.
Ohlig J; Henninger C; Zander S; Merx M; Kelm M; Fritz G
Arch Toxicol; 2018 Jan; 92(1):441-453. PubMed ID: 28710503
[TBL] [Abstract][Full Text] [Related]
4. Two-dimensional speckle tracking echocardiography combined with high-sensitive cardiac troponin T in early detection and prediction of cardiotoxicity during epirubicine-based chemotherapy.
Kang Y; Xu X; Cheng L; Li L; Sun M; Chen H; Pan C; Shu X
Eur J Heart Fail; 2014 Mar; 16(3):300-8. PubMed ID: 24464946
[TBL] [Abstract][Full Text] [Related]
5. The novel butyrate derivative phenylalanine-butyramide protects from doxorubicin-induced cardiotoxicity.
Russo M; Guida F; Paparo L; Trinchese G; Aitoro R; Avagliano C; Fiordelisi A; Napolitano F; Mercurio V; Sala V; Li M; Sorriento D; Ciccarelli M; Ghigo A; Hirsch E; Bianco R; Iaccarino G; Abete P; Bonaduce D; Calignano A; Berni Canani R; Tocchetti CG
Eur J Heart Fail; 2019 Apr; 21(4):519-528. PubMed ID: 30843309
[TBL] [Abstract][Full Text] [Related]
6. Cardiotoxic Effects of Short-Term Doxorubicin Administration: Involvement of Connexin 43 in Calcium Impairment.
Pecoraro M; Rodríguez-Sinovas A; Marzocco S; Ciccarelli M; Iaccarino G; Pinto A; Popolo A
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29019935
[TBL] [Abstract][Full Text] [Related]
7. Beneficial effects of tadalafil on left ventricular dysfunction in doxorubicin-induced cardiomyopathy.
Jin Z; Zhang J; Zhi H; Hong B; Zhang S; Guo H; Li L
J Cardiol; 2013 Aug; 62(2):110-6. PubMed ID: 23731918
[TBL] [Abstract][Full Text] [Related]
8. Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin.
Wang Y; Zheng D; Wei M; Ma J; Yu Y; Chen R; Lacefield JC; Xu H; Peng T
Cardiovasc Res; 2013 Jun; 98(3):381-90. PubMed ID: 23455548
[TBL] [Abstract][Full Text] [Related]
9. Liposomal co-delivered oleanolic acid attenuates doxorubicin-induced multi-organ toxicity in hepatocellular carcinoma.
Sarfraz M; Afzal A; Raza SM; Bashir S; Madni A; Khan MW; Ma X; Xiang G
Oncotarget; 2017 Jul; 8(29):47136-47153. PubMed ID: 28525367
[TBL] [Abstract][Full Text] [Related]
10. Strain echocardiography combined with pharmacological stress test for early detection of anthracycline induced cardiomyopathy.
Burdick J; Berridge B; Coatney R
J Pharmacol Toxicol Methods; 2015; 73():15-20. PubMed ID: 25725313
[TBL] [Abstract][Full Text] [Related]
11. Time course of cardiomyopathy induced by doxorubicin in rats.
Medeiros-Lima DJM; Carvalho JJ; Tibirica E; Borges JP; Matsuura C
Pharmacol Rep; 2019 Aug; 71(4):583-590. PubMed ID: 31174019
[TBL] [Abstract][Full Text] [Related]
12. Cardiac magnetic resonance imaging for the assessment of the myocardium after doxorubicin-based chemotherapy.
Lunning MA; Kutty S; Rome ET; Li L; Padiyath A; Loberiza F; Bociek RG; Bierman PJ; Vose JM; Armitage JO; Porter TR
Am J Clin Oncol; 2015 Aug; 38(4):377-81. PubMed ID: 24192805
[TBL] [Abstract][Full Text] [Related]
13. Phosphodiesterase-5 inhibition with sildenafil attenuates cardiomyocyte apoptosis and left ventricular dysfunction in a chronic model of doxorubicin cardiotoxicity.
Fisher PW; Salloum F; Das A; Hyder H; Kukreja RC
Circulation; 2005 Apr; 111(13):1601-10. PubMed ID: 15811867
[TBL] [Abstract][Full Text] [Related]
14. Thrombopoietin protects against in vitro and in vivo cardiotoxicity induced by doxorubicin.
Li K; Sung RY; Huang WZ; Yang M; Pong NH; Lee SM; Chan WY; Zhao H; To MY; Fok TF; Li CK; Wong YO; Ng PC
Circulation; 2006 May; 113(18):2211-20. PubMed ID: 16651473
[TBL] [Abstract][Full Text] [Related]
15. Early Changes in Myocardial Mechanics Detected by 3-Dimensional Speckle Tracking Echocardiography in Patients Treated With Low Doses of Anthracyclines.
Piveta RB; Rodrigues ACT; Vieira MLC; Fischer CH; Afonso TR; Daminello E; Cruz FM; Galvão TFG; Katz M; Morhy SS
JACC Cardiovasc Imaging; 2018 Nov; 11(11):1729-1731. PubMed ID: 29909102
[No Abstract] [Full Text] [Related]
16. Thyroid hormone plus dual-specificity phosphatase-5 siRNA increases the number of cardiac muscle cells and improves left ventricular contractile function in chronic doxorubicin-injured hearts.
Tan L; Bogush N; Naqvi E; Calvert JW; Graham RM; Taylor WR; Naqvi N; Husain A
Theranostics; 2021; 11(10):4790-4808. PubMed ID: 33754028
[No Abstract] [Full Text] [Related]
17. Cardiac MRI Myocardial Functional and Tissue Characterization Detects Early Cardiac Dysfunction in a Mouse Model of Chemotherapy-Induced Cardiotoxicity.
Naresh NK; Misener S; Zhang Z; Yang C; Ruh A; Bertolino N; Epstein FH; Collins JD; Markl M; Procissi D; Carr JC; Allen BA
NMR Biomed; 2020 Sep; 33(9):e4327. PubMed ID: 32567177
[TBL] [Abstract][Full Text] [Related]
18. Decreased Soluble Guanylate Cyclase Contributes to Cardiac Dysfunction Induced by Chronic Doxorubicin Treatment in Mice.
Vandenwijngaert S; Swinnen M; Walravens AS; Beerens M; Gillijns H; Caluwé E; Tainsh RE; Nathan DI; Allen K; Brouckaert P; Bartunek J; Scherrer-Crosbie M; Bloch KD; Bloch DB; Janssens SP; Buys ES
Antioxid Redox Signal; 2017 Feb; 26(4):153-164. PubMed ID: 27505125
[TBL] [Abstract][Full Text] [Related]
19. Advantages of prophylactic versus conventionally scheduled heart failure therapy in an experimental model of doxorubicin-induced cardiomyopathy.
Lódi M; Priksz D; Fülöp GÁ; Bódi B; Gyöngyösi A; Nagy L; Kovács Á; Kertész AB; Kocsis J; Édes I; Csanádi Z; Czuriga I; Kisvárday Z; Juhász B; Lekli I; Bai P; Tóth A; Papp Z; Czuriga D
J Transl Med; 2019 Jul; 17(1):229. PubMed ID: 31324258
[TBL] [Abstract][Full Text] [Related]
20. Desacyl ghrelin prevents doxorubicin-induced myocardial fibrosis and apoptosis via the GHSR-independent pathway.
Pei XM; Yung BY; Yip SP; Ying M; Benzie IF; Siu PM
Am J Physiol Endocrinol Metab; 2014 Feb; 306(3):E311-23. PubMed ID: 24326424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
